MicroRNA, nutrition, and cancer prevention.

Advances in Nutrition
Sharon A Ross, Cindy D Davis

Abstract

MicroRNA (miRNA) are small noncoding RNA molecules that are involved in post-transcriptional gene silencing. Alterations in miRNA expression are observed in and may underlie many different human diseases, including cancer. In fact, miRNA have been shown to affect the hallmarks of cancer, including sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Genetic and epigenetic alterations may explain aberrant miRNA expression in cancer cells and may also contribute to cancer risk. It is now thought that by circulating through the bloodstream, miRNA can exert their effects at distant sites as well as within the cells of origin. Recent evidence suggests that nutrients and other bioactive food components protect against cancer through modulation of miRNA expression. Moreover, dietary factors have been shown to modify miRNA expression and their mRNA targets in various cancer processes, including apoptosis, cell cycle regulation, differentiation, inflammation, angiogenesis, and metastasis as well as pathways in stress response. Herein, we provide a brief overview of dietary modulation of miRNA expression and i...Continue Reading

References

Dec 6, 2001·Nature Reviews. Genetics·S R Eddy
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Mar 12, 2004·Genes & Development·John G Doench, Phillip A Sharp
May 25, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mark J AndertonDonald E Mager
Jun 21, 2005·Nature Genetics·Isaac BentwichZvi Bentwich
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lin ZhangGeorge Coukos
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Allan J PantuckArie Belldegrun
Aug 23, 2006·Journal of Cellular Biochemistry·Huban KutayKalpana Ghoshal
Nov 17, 2006·Cancer Research·Carmen J MarsitKarl T Kelsey
Nov 23, 2006·Gene·Fabrício F Costa
Jul 4, 2007·Nutrition Reviews·Deanna M Minich, Jeffrey S Bland
Nov 1, 2007·Journal of Cellular Biochemistry·Li Li, Alonzo H Ross
Jan 17, 2008·Nature Reviews. Genetics·Witold FilipowiczNahum Sonenberg
Mar 19, 2008·Molecular Cancer Therapeutics·Michael SunRazelle Kurzrock
Aug 1, 2008·Nutrition Reviews·Cindy D Davis, Sharon A Ross
Sep 27, 2008·FEBS Letters·Sonja GaedickeGerald Rimbach
Oct 28, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alberto IzzottiSilvio De Flora
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Scott M LippmanCharles A Coltman
Dec 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manlio VinciguerraMichelangelo Foti
Mar 10, 2009·The Journal of Nutritional Biochemistry·Wing Pui Tsang, Tim Tak Kwok
Mar 31, 2009·Journal of the American Dietetic Association·Natalie D RiedigerMohammed H Moghadasian
Apr 7, 2009·The FEBS Journal·Qun LinZhong Yun
May 5, 2009·Current Opinion in Cell Biology·Massimo NegriniGeorge A Calin
May 14, 2009·International Journal of Cancer. Journal International Du Cancer·Takuya MohriTsuyoshi Yokoi
May 26, 2009·Cancer Letters·Kai RuanGaoliang Ouyang
Aug 28, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bo WangSamson T Jacob
Sep 3, 2009·Molecular Cancer Therapeutics·Erica SalernoElizabeth S Raveche
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Urszula DoughertyMarc Bissonnette
Jan 7, 2010·Cancer Prevention Research·Alberto IzzottiSilvio De Flora

❮ Previous
Next ❯

Citations

Feb 21, 2013·Cell Biochemistry and Biophysics·Jianling SunYueming Zhang
Jul 17, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qing SunGuangqiao Zeng
Mar 19, 2013·Nutrients·Margaret Joy Dauncey
Apr 11, 2014·International Journal of Biological Sciences·Sen LuXuehao Wang
Apr 9, 2013·Future Oncology·Min ZhengXin-hua Liang
Feb 13, 2015·Molecular Medicine Reports·Zheng ZhengWenhui Ma
Jul 8, 2015·Molecular Medicine Reports·Bijing MaoGe Wang
Feb 4, 2016·Indian Journal of Cancer·S Maduri
Sep 12, 2015·Chemical Biology & Drug Design·Effat AlizadehNosratollah Zarghami
Mar 10, 2016·Nature Reviews. Clinical Oncology·Susan T MayneCheryl L Rock
Nov 26, 2013·Molecular Nutrition & Food Research·Aamir AhmadFazlul H Sarkar
Jul 30, 2015·Canadian Journal of Physiology and Pharmacology·Janos ZempleniJuan Cui
Apr 16, 2015·BioMed Research International·Paola TiberioValentina Appierto
Apr 18, 2015·The Journal of Nutritional Biochemistry·Michael A TsoukasChristos S Mantzoros
Jul 10, 2012·Molecular Aspects of Medicine·F I MilagroJ A Martínez
Jul 16, 2013·Cell Metabolism·Olivier DumortierEmmanuel Van Obberghen
May 21, 2016·The Prostate·Seodhna M LynchDeclan J McKenna
Jun 25, 2016·International Journal of Molecular Sciences·Shawna B Matthews, Henry J Thompson
Nov 9, 2016·Molecular Aspects of Medicine·Archana DhasarathyKate J Claycombe
Jul 1, 2017·Annals of the New York Academy of Sciences·Avinash KumarAnait S Levenson
Sep 28, 2017·International Journal of Molecular Sciences·Nagisa NosratiGopinadhan Paliyath
Jun 29, 2017·Journal of Cellular Biochemistry·Zarrin BanikazemiHamed Mirzaei
Jun 23, 2012·Journal of Cancer Research and Clinical Oncology·Berrin TuncaAyhan Bilir
Dec 22, 2012·Expert Review of Proteomics·Lianhong LiGary Guishan Xiao
Jul 13, 2019·Nutrition and Cancer·Niladri Bag, Arundhati Bag
May 17, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Mukesh Verma
Jul 17, 2013·Advances in Nutrition·Stefan M Pasiakos, James P McClung
Sep 28, 2016·World Journal of Gastroenterology : WJG·Kyungjin Lee, Lynnette R Ferguson
Jun 9, 2015·Current Pharmacology Reports·Nadire DuruQun Zhou
Feb 16, 2016·World Journal of Gastroenterology : WJG·Amanda Ferreira VidalÂndrea Ribeiro-dos-Santos
Feb 9, 2017·PPAR Research·Dorothea PortiusMichelangelo Foti
Aug 2, 2017·Oxidative Medicine and Cellular Longevity·Deborah de Almeida Bauer GuimarãesAnderson Junger Teodoro
Feb 9, 2016·World Journal of Gastroenterology : WJG·Vishal ChandraRajani Rai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.